This final article in the supplement aims to summarize a clinical approach for weight management geared toward primary care practitioners, offering practical advice about how to integrate weight management into day-to-day practice. To achieve long-term successful weight loss, a comprehensive multimodal approach is recommended, focusing on both lifestyle modification and appropriate use of therapy. Once-weekly subcutaneous semaglutide 2.4 mg is a novel treatment that can be used as an adjunct to lifestyle modification for the management of overweight and obesity. Key considerations are presented to support its optimal administration in conjunction with lifestyle modification, with a focus on assessing suitability and the importance of dose escalation and monitoring.
Kyrillos, Janine V.; Skolnik, Neil S.; Mukhopadhyay, Bhasha; and Pennings, Nicholas, "Integrating Semaglutide Into Obesity Management - A Primary Care Perspective" (2023). Jefferson Hospital Staff Papers and Presentations. Paper 24.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
This article is the author's final published version in Postgraduate Medicine, Volume 134, Sup. 1, Pg. 37-49.
The published version is available at https://doi.org/10.1080/00325481.2022.2149964. Copyright © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.